A Perspective Phase I and II Trial of Liposome-encapsulated Doxorubicin (TLC D-99) in Combination With Ifosfamide in Patients With Metastatic Soft Tissue Sarcoma.
Phase of Trial: Phase I/II
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Ifosfamide (Primary)
- Indications Sarcoma
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2009 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2008 Planned number of patients added (36) as reported by ClinicalTrials.gov.